Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-21

FDA Approved: GUANFACINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA granted approval of a supplemental application for guanfacine from Actavis Pharma, enabling the generic version to be marketed. This approval pertains t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

SUPPL AP for GUANFACINE (GUANFACINE)